Mode
Text Size
Log in / Sign up

Opioid Safety Toolkit increases naloxone requests (OR 2.5) and overdose knowledge compared to standard informationInteractive safety tools help patients request life-saving overdose medication

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider using interactive Opioid Safety Toolkits to increase naloxone request rates and patient knowledge of overdose risks.

This randomized controlled trial enrolled 314 adults prescribed opioids for non-cancer pain to evaluate an interactive Opioid Safety Toolkit against an active control website providing evidence-based information. The primary outcome was self-reported naloxone requests at four weeks post-intervention.

Participants using the Opioid Safety Toolkit reported significantly higher rates of naloxone requests (21.7%) compared to the control group (9.9%; OR 2.5; 95% CI [1.3, 4.8]; P = 0.005). Additionally, intentions to access naloxone immediately after the intervention were higher in the toolkit group (41.4%) than the control group (15.4%; OR 3.9; 95% CI [2.3, 6.6]; P < 0.001). The toolkit also resulted in higher mean scores for opioid overdose knowledge (16.6 vs 13.3) and higher satisfaction ratings (20.0 vs 18.0; P = 0.035).

No significant difference was observed between the groups regarding healthcare provider discussions about opioid safety at four weeks (OR 1.1; P = 0.620). A primary limitation of this study is the reliance on self-reported outcomes. The findings suggest that interactive educational content may enhance patient knowledge and proactive measures for overdose prevention compared to standard information delivery.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in patient education regarding opioid safety. While previous coverage noted that opioids provide clinically important pain relief for short durations (less than or equal to 4 weeks) and that various interventions like intercostal nerve cryoablation or ERAS pathways can reduce total opioid consumption, this study specifically evaluates the efficacy of educational tools to improve patient preparedness for potential overdose complications.

Living with chronic pain often requires using opioids, but these medications carry a serious risk of overdose. To help manage this risk, researchers tested an interactive "Opioid Safety Toolkit" designed to educate patients on how to stay safe while managing their pain.

In a study involving 314 adults in Australia, the group using the interactive toolkit showed much higher engagement with safety measures than those using a standard information website. Specifically, more people in the toolkit group reported wanting to get naloxone—a medication that can reverse an opioid overdose—and actually requested it four weeks later. They also scored higher on tests regarding their knowledge of how to prevent overdoses.

While the interactive tools were very effective at improving patient knowledge and intent to act, they did not change how often patients talked to their doctors about safety. Because the results relied on what patients reported themselves, there is some room for caution in the data, but the evidence suggests that tailored, interactive content is a strong way to reach people with these concerns.

What this means for you:
Interactive educational tools significantly improve patient knowledge and naloxone requests for those on opioids.

Common questions

What is naloxone?

Naloxone is a medication used to reverse the effects of an opioid overdose. In this study, the interactive toolkit helped patients better understand how to get and use this life-saving medicine.

How did the interactive toolkit help patients?

The toolkit provided tailored educational content. Compared to a standard website, it led to higher scores in overdose knowledge and significantly more people reporting an intent to get naloxone immediately after using the tool.

Did the program change how patients talked to their doctors?

No, the study found that there was no significant difference in the number of discussions about opioid safety between the group using the interactive toolkit and those using the standard website.

Study Details

Study typeRct
EvidenceLevel 2
PublishedAug 2026
View Original Abstract ↓
BACKGROUND AND AIMS: Prescription opioid-related harm remains a significant public health concern. This study aimed to evaluate the efficacy of the Opioid Safety Toolkit, a co-designed, interactive online resource, in increasing naloxone uptake and healthcare provider discussions among adults prescribed opioids for pain. DESIGN: Parallel-group, open-label, randomised controlled trial. SETTING: Community-based, online recruitment across Australia. PARTICIPANTS: Adults (n = 314) prescribed opioids for non-cancer pain. INTERVENTIONS: Participants were randomised to receive either the Opioid Safety Toolkit (intervention, n = 152), which included interactive and tailored educational content on opioid safety, or an active control website presenting evidence-based opioid safety information (n = 162). Both groups were followed for four weeks. MEASUREMENTS: The primary outcome was self-reported naloxone requests four weeks post-intervention. Other outcomes were intentions to access naloxone immediately post-intervention, and healthcare provider discussions about opioid safety at four weeks, opioid safety knowledge (immediately after the intervention and at four weeks), satisfaction with resources and naloxone possession at four weeks. FINDINGS: Participants in the intervention group were more likely to have requested naloxone at four weeks compared with controls [21.7% vs 9.9%, odds ratio (OR) = 2.5, 95% confidence interval (CI) = 1.3, 4.8; P = 0.005], and more likely to report intentions to access naloxone immediately post-intervention compared with controls (41.4% vs 15.4%, OR = 3.9, 95% CI = 2.3, 6.6; P < 0.001). Participants in the intervention group were not more likely to have healthcare provider discussions at four weeks compared with controls (OR = 1.1, 95% CI = 0.7, 1.8; P = 0.620). Post-intervention opioid overdose knowledge was statistically significantly higher in the intervention group compared with control group (Mean score 16.6, 95% CI = 15.5, 17.7 vs control mean score 13.3, 95% CI = 12.3, 14.3). Satisfaction with the resource was higher in the intervention group compared with control group (Mean = 20.0, 95% CI = 18.7, 21.3 vs Mean = 18.0, 95% CI = 16.7, 19.3, P = 0.035). CONCLUSIONS: We found good evidence that, compared with a gold-standard opioid information website, the Opioid Safety Toolkit increased naloxone requests among Australian adults prescribed opioids for non-cancer pain. We also observed consistent effects across secondary outcomes, with the Toolkit increasing intentions to access naloxone, enhancing opioid overdose knowledge and yielding higher satisfaction ratings, although it did not increase healthcare provider discussions at four weeks.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.